ImageneBio, Inc. (IMA)
5.76
-0.04
(-0.69%)
USD |
NASDAQ |
Dec 29, 13:54
ImageneBio Shareholders Equity (Quarterly): 139.83M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| CEL-SCI Corp. | 7.025M |
| AIM ImmunoTech, Inc. | -6.077M |
| IGC Pharma, Inc. | 8.092M |
| NovaBay Pharmaceuticals, Inc. | 1.634M |
| Protalix Biotherapeutics, Inc. | 52.91M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 160.88M |
| Total Liabilities (Quarterly) | 21.05M |
| Debt to Equity Ratio | 0.0783 |
| Current Ratio | 13.24 |
| Net Debt Paydown Yield | -0.41% |